Author: Zhiheng Xu; Jianmeng Zhou; Yongbo Huang; Xuesong Liu; Yonghao Xu; Sibei Chen; Dongdong Liu; Zhimin Lin; Xiaoqing Liu; Yimin Li
Title: The efficacy of convalescent plasma for the treatment of severe influenza Document date: 2020_2_23
ID: 4pe9o59g_4
Snippet: It has been suggested that administration of high-titre anti-influenza immune plasma, derived from convalescent or immunised individuals, may yield a clinical effect for treatment of seasonal and pandemic influenza of viral etiology (9-11). It was reported that convalescent plasma treatment reduced the hospital stay and mortality in patients with SARS-CoV infection and severe influenza A (H1N1) (9, 12). Furthermore, systematic reviews of studies .....
Document: It has been suggested that administration of high-titre anti-influenza immune plasma, derived from convalescent or immunised individuals, may yield a clinical effect for treatment of seasonal and pandemic influenza of viral etiology (9-11). It was reported that convalescent plasma treatment reduced the hospital stay and mortality in patients with SARS-CoV infection and severe influenza A (H1N1) (9, 12). Furthermore, systematic reviews of studies using convalescent plasma also found evidence of clinical benefit for such patients (9, 13). Therefore, convalescent plasma may be promising in patients with SARS-CoV-2 infection (COVID-19), particularly in those presented with critical illness.
Search related documents:
Co phrase search for related documents- anti influenza immune plasma and convalescent plasma treatment: 1
- anti influenza immune plasma and immune plasma: 1, 2, 3, 4
- anti influenza immune plasma and plasma treatment: 1, 2
- anti influenza immune plasma and SARS cov: 1
- clinical benefit and convalescent plasma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- clinical benefit and convalescent plasma treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- clinical benefit and critical illness: 1, 2, 3, 4, 5, 6, 7, 8
- clinical benefit and hospital stay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
- clinical benefit and immune plasma: 1, 2, 3, 4, 5, 6
- clinical benefit and mortality hospital stay: 1, 2, 3, 4, 5, 6, 7, 8
- clinical benefit and plasma treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- clinical benefit and SARS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- clinical benefit and SARS cov infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53
- clinical benefit and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58
- clinical benefit and SARS infection patient: 1
- clinical benefit and viral etiology: 1
- clinical effect and convalescent plasma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- clinical effect and convalescent plasma treatment: 1, 2, 3, 4
- clinical effect and critical illness: 1, 2, 3, 4, 5, 6, 7
Co phrase search for related documents, hyperlinks ordered by date